These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5357139)

  • 21. [Clinical trial of rifampicin as sole therapy. Study of serum levels].
    Brouet G; Modaï J; Vergez P
    Rev Tuberc Pneumol (Paris); 1969; 33(1):27-42. PubMed ID: 5360580
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study on rifampicin applied every other day for severe cavitary pulmonary tuberculosis (author's transl)].
    Kitatani F; Fujimoto S; Asahi T; Konishiike J; Sera Y
    Kekkaku; 1974 May; 49(5):133-8. PubMed ID: 4408937
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience with the use of rifampicin (rimactan) in patients with chronic destructive forms of pulmonary tuberculosis].
    Ginzburg ZI
    Probl Tuberk; 1971; 49(12):77-8. PubMed ID: 5145746
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preliminary results of treatment of pulmonary tuberculosis with rifampicin].
    Pozzi G; Ferraro S
    G Ital Mal Torace; 1969; ():Suppl 2:17-31. PubMed ID: 5357135
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rifampicin in the treatment of tuberculosis in patients with diabetes mellitus].
    Markova EF; Gortsunian DK
    Probl Tuberk; 1987; (6):39-41. PubMed ID: 3628210
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic effect of Rifampicin on re-treatment cases of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):227-35. PubMed ID: 5449510
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 1. A preliminary study. The results of Rifampicin treatment for advanced pulmonary tuberculosis resistant to conventional antituberculous drugs].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):251-6. PubMed ID: 5460317
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 30. [Humoral and bacteriological findings in patients with pulmonary tuberculosis during rifampicin therapy].
    Stringa C
    G Ital Mal Torace; 1969; ():Suppl 2:107-8. PubMed ID: 5357133
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical observations on the use of Rifampicin].
    Filograna V
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):477-80. PubMed ID: 5309061
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preliminary clinical studies on the use of a new oral rifamycin (Rifaldazine) in the therapy of pulmonary tuberculosis. (Preliminary note)].
    Moncalvo F; Moreo G
    G Ital Mal Torace; 1966; 20(3):120-31. PubMed ID: 5974175
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience with endobronchial and local use of rifampicin in tuberculosis].
    Abdurashitova MV; Stoianovskiĭ EA; Fok AIa
    Probl Tuberk; 1976 Jan; (l):35-8. PubMed ID: 995905
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of therapeutic effects of rifampicin 450 mg daily and 600 mg three times weekly on the previously treated pulmonary tuberculosis patients].
    Yamamoto M; Mizutani A; Nakamura H; Hirose H; Nagata A
    Kekkaku; 1973 May; 48(5):197-202. PubMed ID: 4732658
    [No Abstract]   [Full Text] [Related]  

  • 35. Rifampicin in the treatment of drug-resistant tuberculosis. A report on 13 patients with pulmonary and one patient with renal disease.
    Engbaek HC; Vergmann B
    Scand J Respir Dis; 1970; 51(1):11-27. PubMed ID: 5456856
    [No Abstract]   [Full Text] [Related]  

  • 36. [Direct effect of rifampicin on acid formation and motor function of the stomach in tuberculous patients].
    Petrenko VM
    Probl Tuberk; 1979 Nov; (11):47-50. PubMed ID: 530969
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinico-immunological substantiation of the use of rifampicin in the combined therapy of adults and adolescents with destructive pulmonary tuberculosis].
    Chernushenko EF; Kogosova LS; Il'nitskiĭ IG; Petrashenko AI; Goncharova SI
    Probl Tuberk; 1989; (7):39-43. PubMed ID: 2798385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical trial with rifampicin i.v. 300 and 600 in tuberculosis patients].
    Jungbluth H
    Prax Klin Pneumol; 1984 May; 38(5):177-81. PubMed ID: 6379634
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rifampicin in chronic pulmonary tuberculosis].
    Levit T; Terracina S; Karman S
    Harefuah; 1971 Jun; 80(11):604-6. PubMed ID: 5157984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.